Project Description

Published in the Journal of Neuroscience is the joint study from McGill, Padua and Toronto universities showing that the use of a new drug targeting MT1 melatonin receptors selectively affects REM sleep without altering non-REM sleep. Significant is the clinical potential of the finding especially in certain diseases